Management of Trazodone-Induced Tardive Dyskinesia
Diagnosis and Immediate Management
- The American College of Physicians recommends discontinuing trazodone immediately if clinically feasible, as medication discontinuation is the primary treatment for drug-induced dyskinesia 1, 2
- The American Academy of Family Physicians suggests that gradual taper over 10-14 days may limit withdrawal symptoms, though in documented trazodone-induced TD cases, rapid discontinuation led to symptom improvement 3
- Monitoring for improvement over the next few days to weeks is crucial, as early discontinuation offers the best chance for symptom resolution 1
Alternative Sleep Management
- The American Academy of Sleep Medicine recommends considering non-pharmacologic sleep interventions first, such as sleep hygiene and cognitive behavioral therapy for insomnia, to avoid further medication exposure 3
- If medication is necessary for insomnia, alternatives include short-acting benzodiazepines, zolpidem, melatonin, or melatonin receptor agonists, and low-dose mirtazapine if antidepressant properties are also needed 3
Assessment and Monitoring
- The American Psychiatric Association recommends performing a baseline assessment using the Abnormal Involuntary Movement Scale (AIMS) to objectively document the severity of jaw movements 1, 2
- Monitoring every 1-2 weeks initially after trazodone discontinuation is necessary to assess for improvement 1
Pharmacologic Treatment for Persistent TD
- The American Academy of Neurology recommends treating moderate to severe or disabling TD with a VMAT2 inhibitor (valbenazine or deutetrabenazine) as first-line pharmacotherapy 1, 4
- These medications have demonstrated efficacy in class 1 studies and are the only FDA-approved medications specifically for tardive dyskinesia 1
Critical Pitfalls to Avoid
- The American College of Physicians advises against increasing or adding antipsychotic medications, as this may temporarily mask symptoms but will worsen TD long-term 1
- The American Academy of Family Physicians warns against prescribing anticholinergics for TD, as they are ineffective and may worsen symptoms 1, 4